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ABSTRACT 
Introduction: Atopic dermatitis (AD) is a chronic, recidive inflammatory skin disease 
that is associated with hyper-reactivity of the immune response to environmental 
allergens. LL-37 is an antimicrobial peptide which plays an important role in the 
pathogenesis of AD. Several studies conducted to find out LL-37 expression on the skin 
of patients showed varying and contradictory results. Studies aimed to find out the 
association of LL-37 levels in circulation with AD degree of severity are still very 
limited. The aim of this study are to determine the relationship between serum LL-37 
levels and Scoring Atopic Dermatitis (SCORAD) score and to determine the 
relationship between serum LL-37 levels and the severity of atopic dermatitis. 
Method: This study is analytic observational cross sectional study. The subjects are 30 
patients with AD who came to Outpatient Care for Dermatovenereology and Outpatient 
Care for Pediatric Allergy in dr.Saiful Anwar General Hospital (RSSA) Malang and 
fulfilled the inclusion and exclusion criteria. The subjects are grouped into 2 groups 
based on AD severity, i.e. mild and moderate-severe based on SCORAD index. The 
measured variable is serum LL-37 levels with enzyme-linked immunosorbent assay 
(ELISA) method. 
Results: The mean serum LL-37 levels are 12.4±6.7 ng/ml for mild degree AD and 
9.4±6.06 ng/ml for moderate/severe degree AD. Statistical analysis using Pearson 
parametric statistic test shows no significant correlation (p> 0.05) between serum LL-
37 levels and SCORAD score in patients with AD. Serum levels of LL-37 in this study 
are lower than the normal score in circulation. 
Conclusions: LL-37 serum levels in AD do not experience an increase and is not 
related to SCORAD score. 
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INTRODUCTION 
Atopic dermatitis (AD) is a 
chronic residive skin inflammatory 
disease associated with hyper reflexibility 
of the immune response to environmental 
allergens (1). Based on the records of the 
Indonesian Pediatric Dermatology Study 
Group, AD cases in 2013 were 11.8% (2). 
Based on the data obtained from the 
medical record of Outpatient Care for 
Dermato-venereology of dr. Saiful Anwar 
General Hospital Malang from 2009-
2013, the percentages of patients with AT 
reached 2.14% of all patients 
(Unpublished). Atopic dermatitis is a 
disease that has psychosocial and 
economic impact, and it also has 
considerable contribution in health 
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financing (3,4). AD pathogenesis 
is the result of a complex interaction 
between genetic and environmental 
factors, exacerbated by defects in the skin 
barrier and dysregulated immune 
responses (5). Inflammation in AD lesions 
is biphasic with the dominance of Th-2 
immune responses in the acute phase, 
followed by the dominance of Th-1 
immune responses in chronic phase (1). 
Initiation of inflammation in AD is not 
clearly known. The presence of lesion in 
the epidermis due to scratching, exposure 
to environmental allergens, and microbial 
colonization leads to inflammation(6). 
Dysregulation of the immune response in 
the acute phase affects the expression of 
LL-37, an antimicrobial peptide 
considered to have an important role in 
the pathogenesis of AD(7,8). Several 
studies aimed to determine the 
relationship between LL-37 expression in 
skin tissue and the severity of  AD lesions 
have been done with varying, and 
sometimes, contradictory results. So far, 
researches that aim to determine the 
relationship between LL-37 levels in the 
circulation and the degree of severity of 
AD are still very limited. To the extent of 
the author's knowledge, studies aimed to 
determine the relationship between serum 
LL-37 levels and severity of AD in 
Indonesia have not been found. 
 
SUBJECTS AND METHODE 
 
The research design used in this 
research is analytic observational cross 
sectional which aims to determine the 
relationship between serum LL-
37levelsand SCORAD score in AD. 
Research sample in this research is all 
research population that fulfilled inclusion 
and exclusion criteria and visited 
Outpatient Care for Dermatovenereology 
and Outpatient Care for Pediatric Allergy 
of dr.Saifulanwar General Hospital 
Malang. 
 
Procedures in Measuring Degree of 
Severity 
The diagnosis of AD and the 
determination of the degree of severity 
were performed by anamnesis, physical 
examination with typical clinical features 
according to Hanifin Rajka and SCORAD 
criteria by two consecutive examiners on 
the same day (9,10). 
 
Specimen Collection and Handling 
Procedures 
Collect blood samples in tubes 
containing citrate, heparin or EDTA. 
Centrifuge for 10 minutes at 1,000X g in 
30 minutes. The plasma samples must be 
tested immediately or stored in 
temperatures <-20°C. Avoid repeated 
freezing cycles. The plasmaspecimen 
should be clear and not hemolytic. 
 
Measurement Procedure of Serum LL-
37 Level 
Serum LL-37 level is determined 
from 5 ml of veined blood sample using 
venoject and vaccutainer from the median 
cubital vein. The blood sample is then 
centrifuged; the serum is taken and 
measured using ELISA kit. 
 
Processing and Data Analysis 
Technique 
After filling the data on the data 
collection sheets, the data is then 
processed using Statistical Package for 
Social Sciences (SPSS) version 15. The 
correlation is tested using the Pearson test 
formula if the distribution is normal and 
homogeneous. If the distribution is 
abnormal and not homogeneous, then a 
non parametric statistical test is performed 
by using Spearman test(11). 
 
RESULTS 
 
Subject Basic Data  
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To determine whether or not there 
is a difference in subject basic data based 
on DA category, cross tabulation 
(crosstab) followed by T test and Mann-
Whitney test is carried out to find out the 
homogeneity of the data. Table 1 shows 
that the characteristics of the subjects 
which consist of age, gender, SCORAD 
score and its components in mild category 
and moderate/severe category are 
significantly different.Meanwhile, the 
result of measurement of total serum IgE 
level and peripheral blood eosinophil 
percentage does not show significant 
difference between 2 study groups. 
Table1. Subject Basic Data by Category 
of Atopic Dermatitis 
Characteris
tics 
DA n(%) 
Total 
p 
valu
e 
Mild 
(n=14
) 
Moderat
e/Severe 
(n=16) 
Age (year) 21.14
±7,24 
21.56±7,
38 
21.37
±7,19 
0.8
77* 
Gender 
Male 
female 
 
4(28.
6) 
10(71
.4) 
 
6(37.5) 
10(62.5) 
 
10(33.
3) 
20(66.
7) 
0.6
97*
* 
SCORAD 21.29
±3.3 
38.50±6.
89 
30.47
±10.2
8 
0.0
00*
* 
Extension 10.71
±7.22 
26.50±1
7.29 
19.13
±15.5
6 
0.0
03*
* 
Lesion 
width 
3.43±
0.51 
6.13±1.4
1 
4.87±
1.74 
0.0
00*
* 
Subjective 
symptoms 
6.71±
3.02 
11.81±3.
49 
9,433
±4,13 
0,0
00*
* 
Total 
serum IgE 
level 
170(4
3.76-
2579) 
316,75(7
2.43-
4495) 
- 
0.2
40* 
Peripheral 
Eosinophil
Percentage 
3.41±
1.82 
4.28±2.6
5 
3.88±
2.30 
0.3
12*
* 
*p<0,05 used Mann-Whitney 
** p<0,05 used T-test 
 
The measurement result of serum LL-37 
levels in 2 study groups shows a 
statistically insignificant difference, with 
the mean in mild DA group being 
relatively higher than the mean in 
moderate/severe group. 
 
Table 2. The Measurement Result of 
Serum LL-37 Levels 
serum LL-37 level 
(ng/ml) 
 
DA n=30
Mild n=14 Moderate/severe n=16
Mean 
SD (standard deviation) 
12.4 
6.7 
* p<0,05 used T-test 
 
Correlation between Serum LL-37 
Levels and SCORAD Score and Its 
Components 
The relationship between serum LL-37 
levels and SCORAD score is tested by the 
Pearson Correlation test (Table 3). Based 
on the results of Pearson test analysis, 
correlation coefficient of-0.238 with p = 
0.205 is obtained, so it can be concluded 
that there is no relationship between 
serum LL-37 levels and SCORAD score. 
 
Table 3. Correlation between Serum 
LL-37 Level and SCORAD Score and 
Its Components 
Characteristics serum LL-37 levels 
 R p 
SCORAD 
category -0.238 0.205 
Lesion width -0.264 0.159 
Lesion intensity -0.358 0.052 
Subjective 
symptoms -0.092 0.628 
 
Correlation between LL-37 Serum 
Levels and Several Clinical and 
Laboratory Parameters 
In this study, LL-37 levels are also 
correlated with age, gender, total serum 
IgE levels and percentage of eosinophil in 
peripheral blood. The result of Pearson 
correlation test shows that there is a 
significant relationship between age and 
serum LL-37 levels with correlation 
coefficient of 0.405 with p = 0.026. 
 
Table 4. Correlation between Serum 
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LL-37 Levels and Several Clinical and 
Laboratory Parameters 
Characteristics serum LL-37 levels 
 R p 
Gender -0.317 0.088 
Age 0.405 0.026 
Total serum IgE 
levels -0.215 0.254 
Eosinophil count -0.094 0.621 
 
The study involved30ADpatients with 
ages ranging from 9 to 35 years, and the 
highestpercentageis in the age group17-25 
years old (56.67%). The number of female 
subjects is higher when compared to male 
subjects in mild and moderate/severe AD 
groups. The ratio of women is bigger than 
men because most subjects are in 17-25 
age group. In general, the incidence of 
ADin female is higher than that in male 
with a ratio of 1.3: 1.0 (5). A research 
conducted by Silverberg & Haniffin (12) 
found that AD prevalence in adult was 
3.2% with female having bigger ratio than 
male. The relationship between gender 
and the prevalence of AD is not clearly 
known(13). It is thought that the high 
prevalence of ADin women isdue to 
differences in patterns of genetic 
interaction with the environment during 
childdevelopment. Another factor is the 
possibility of a misdiagnosis in cases of 
allergic contact dermatitis or irritant 
contact dermatitis commonly occurs in 
girls, resulting in a prevalence bias(14). 
Differences in the prevalence of AD in 
each region in the world are related to the 
magnitude of environmental influence on 
the development of AD(4). The grouping 
ofresearch subjects based on mild and 
moderate-severe AD categories is due to 
the disproportionate number of subjects 
related to the sampling method used(11). 
A study conducted by Willemsen, et al 
(2009)(15) on the severity of AD found 
that most AD patients were included in 
mild AD category. In this study, 1 severe 
AD subject, 15 moderate AD subjects, and 
14 mild AD subjects were obtained. In the 
sampling for research on seasonally-
influenced diseases, it is recommended to 
have a longer period(16). This study was 
conducted within 3 months with patients 
having atopic dermatitis with clinical 
manifestations influenced by climate and 
environment as the research subjects(17). 
Atopic dermatitis is considered as 
skin manifestation of a systemic 
abnormality characterized by elevated   
Serum IgE levels and peripheral 
eosinophilia(6). The measurement of total 
serum IgE levels is a rough screening 
method for detecting AD, and it is 
important to measure the severity of the 
disease and the evaluation of the result of 
therapy(18,19). Eosinophil is one of the 
factors that influence the mechanism of 
inflammation in AD skin lesions. The 
dominance of Th-2 immune response in 
AD is characterized by an increase in IL-5 
secretion that triggers formation, 
activation, and chemotaxis, as well as 
eosinophil apoptosis deceleration(20). 
Eosinophil cell infiltration in AD skin 
lesions triggers IL-12 secretion that 
affects the process of immune response 
switching in acute and chronic AD 
lesions. An increase in eosinophil count in 
the circulation may be related to the 
degree of AD severity, but may also be 
considered as a variable of laboratory 
parameter(21). In AD the dysregulation of 
immune response is indicated by the 
increase of total serum IgE(19). In this 
study, measurement of total serum IgE 
levels and eosinophil count in peripheral 
blood are conducted. Increased serum 
total IgE levels were obtained in 73.3% of 
subjects, with moderate/severe AD group 
being relatively higher than mild AD 
group, but not statistically significant. The 
measurement of eosinophil count in 
peripheral blood between mild AD group 
and moderate AD group was not 
DISCUSION 
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significantly different. In a research 
conducted by Ahmed & Nasreen 
(2007)(18)in child population, it was 
found that elevated serum IgE levels were 
obtained in 70% of subjects, and were 
associated with the severity of the disease. 
In a literature review, it was found that 
elevated IgE levels were obtained in 80% 
of patients with AD. Increased levels of 
IgE can be found in individuals without 
AD. On the contrary, normal IgE levels 
can be found in patients with AD(18). A 
study aimed at finding out the relationship 
between peripheral eosinophilia and the 
degree of AD severity still has a 
contradictory result. This study was 
similar to that of Jerenowicz (2007)(21) 
where no significant correlation was 
found between the percentage of 
eosinophil in peripheral blood and the 
degree of AD severity. The examination 
result of two laboratory parameters in this 
study is a variable of laboratory 
parameters or secondary phenomenon in 
AD. 
This study aims to determine the 
relationship of LL-37 levels in circulation 
and SCORAD score in patients with AD. 
The result shows that serum LL-37 level 
in mild AD group is relatively higher than 
L serum L-37 level in moderate/severe 
AD group although it is not statistically 
significant. There is no statistically 
significant correlation between serum LL-
37 level and SCORAD score which 
depicts the severity of AD (r=-0.238, 
p=0,205), so it is concluded that Ho is 
accepted. Based on previous research, the 
role of LL-37 in pathogenesis of AD is not 
clearly known. A study conducted by Goo 
et al (2010)(22) aimed to determine the 
basal expression of LL-37 in the skin of 
AD patients. The result showed that basal 
LL-37 expression in the skin of AD 
patients was not different from normal 
individual skin. The study by Mallbris et 
al (2009)(23) aimed to determine the 
expression of LL-37 in skin lesions of AD 
patients compared to normal individuals 
and psoriasis sufferers. Psoriasis is a skin 
inflammatory disease whose pathogenesis 
is associated with LL-37 expression. The 
result showed that LL-37 expression in 
skin lesions of AD patients was lower 
when compared to skin lesions of 
psoriasis patients, whereas LL-37 
expression on skin without lesions was 
almost the same among AD patients, 
psoriasis sufferers, and normal 
individuals. Lesion in the epidermis can 
cause low LL-37 expression in AD skin 
due to the dominance of Th2-immune 
responses that suppress pro-inflammatory 
activities of LL-37. A research conducted 
by Ballardini et al (2009)(24) indicated 
that LL-37 expression increased in the 
skin of patients with lesions, which was 
related to the process of tissue re-
epithelialization.  
A previous research aimed to 
determine the association of LL-37 levels 
in circulation with the degree of severity 
by Leung et al. in 2012, showed a 
significant correlation between serum LL-
37 levels with total SCORAD score (r = 
0.181; p = 0.030) and objective SCORAD 
(r = 0.207; p = 0.013) in children  
subjects. Therefore, it is concluded that 
serum LL-37 levels can be used as a 
marker of ADseverity(25). LL-37 has 
complex functions and roles. The role of 
LL-37 in the inflammatory process is 
influenced by the type of cell and the 
underlying disease. Activation of LL-37 
as an immunomodulator is mediated by 
several different pathways. Until now, it is 
very difficult to conduct research that 
aims to determine the role of LL-37 
separately because of its activities that 
overlap and run simultaneously(7,26). 
LL-37 is expressed in tissue and 
circulation. In vitro studies to measure 
LL-37 expression in keratinocyte cell 
culture have some limitations with respect 
to the process of cell differentiation(22). 
The mechanism of LL-37 induction in 
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tissue or circulation is still uncertain. Both 
local and systemic infections and 
inflammations can induce LL-37 
expression in the tissues and circulation 
(7). Some local and systemic 
inflammatory diseases are associated with 
LL-37 expression, for example psoriasis 
vulgaris, rosacea, lupus erythematosus, 
hidradenitis suppurative, and rheumatoid 
arthritis. Other inflammatory conditions 
that can affect the expression of LL-37 are 
periodontitis, gastrointestinal infections, 
urinary tract infections and genital tract, 
as well as respiratory tract infections. The 
expression of LL-37 is set in a balanced 
condition to maintain homeostasis. Some 
physiological conditions may also affect 
the expression of LL-37, such as the 
conceptus, childbirth, and the overgrowth 
of the body's microflora(27). In this study 
local and systemic inflammatory diseases 
are excluded by the criteria of sample 
rejection, but some uncontrollable 
physiological conditions may affect the 
results of the study. Psychological stress 
may decrease antimicrobial peptide levels 
in the skin through endogenous 
glucocorticoid secretion (28). The 
mechanisms underlying the influence of 
psychological stress on antimicrobial 
peptide expression are unclear. 
Psychological stress may increase 
endogenous glucocorticoid levels which in 
turn lead to inhibition of epidermal lipid 
synthesis which affects the production of 
lamellar bodies in the epidermis, thus 
suppressing the level of LL-37 in the skin 
(28). The relationship between LL-37 
expression in tissue and circulation is still 
unclear. Until now there has not been any 
study that compares basal expression of 
LL-37 in circulation with various 
physiological and pathological conditions. 
Levels of LL-37 obtained in this 
study ranged from 9.40±6.06 ng/ml to 
12.4±6.7 ng/ml, lower when compared to 
normal levels in circulation (plasma = 50-
80 ng/ml)(29,30). The type of sample is 
presumed to have an effect on the research 
result. Several coagulation factors are not 
obtained in serum samples. In a literature 
it is said that the components of proteins 
in the blood can be affected by the loss of 
several coagulation factors. However, 
until now there has not been any data on 
the effect of this type of sample on LL-37 
circulation(31). 
In some literature studies it is 
known that elevated serum total IgE levels 
and peripheral blood eosinophil counts 
may reflect increased expression of Th-2 
immune response in AD, but it is said that 
this condition is inconsistent (32,33). Th-2 
cytokines i.e. IL-4 and IL-13, are 
cytokines that play a role in IgE secretion. 
It is considered that serum IgE levels can 
be used as a marker of the expression of 
Th2 cytokines (IL-4 and IL-13). In this 
study there is no significant correlation 
between serum LL-37 levels and total 
serum IgE levels and the percentage of 
eosinophil counts in peripheral blood, so it 
can be concluded that the effect of Th2 
immune response on circulation is not 
related to total serum IgE levels and 
peripheral blood eosinophil percentage. 
The result shows that there is a 
statistically significant correlation 
between serum LL-37 levels and age of 
the subjects, with r=0.405, p=0.026. In a 
literature study, it is known that LL-37 
levels in saliva are directly proportional to 
the age of individuals (27)jk. So far the 
researchers have not found any studies 
that examine the correlation between 
serum LL-37 levels and age of the 
subjects. Further research is needed to 
determine the effect of age on LL-37 
circulation expression. 
Biological factors affecting 
regulation of LL-37 expression are 
enormous, thus resulting in considerable 
bias in this study. In AD there are several 
abnormalities in the immune system, both 
systemic and specific to the skin (6). 
Genetic diversity in AD is one of the 
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causes of the limitations in this study. The 
proportion of unbalanced subjects with a 
relatively small number of subjects may 
influence the results of the study. The 
method used to measure some parameters 
can also be the cause for bias in the 
research results because the element of 
subjectivity and accuracy is not high 
enough.  
 
CONCLUSION 
 
From the results of this study it can 
be concluded that serum LL-37 levels are 
not related to SCORAD score in AD, so 
they can not be used to assess the degree 
of severity of AD. 
 
FUTURE DIRECTIONS 
 
Research with more proportional 
subjects using more representative 
methods is needed to obtain more 
significant data and may reduce the bias in 
the study. 
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